TransMedics Clocks Small-Than-Expected Q3 Loss, Boosts FY22 Guidance

TransMedics Group Inc (NASDAQ: TMDX) posted a Q3 EPS loss of $(0.25), better than the consensus of $(0.41) and $(0.47) a year ago. Net revenue of $25.7 million increased 378% Y/Y, beating the consensu...